Abstract: A flow through dispenser for the drop-wise dispensation of liquid which arrangement comprises: a housing (104) comprising: (i) a flow through microconduit (105) with an upstream end (106) and a downstream end (outlet) (107); and (ii) a dispenser orifice (108) between these two ends, and an inlet tube (110) which is attached to the upstream end (106) and provides an inlet (111) that can be connected to a liquid storage (112) for liquid (113) that is to be transported in flow through microconduit (105) and inlet tube (110) and/or dispensed through the orifice (108). The inner volume between the inlet and the downstream end is is ?10 ?l. An instrument set-up for drop-wise dispensation of liquid to target areas of a microdevice.

Abstract: A liquid transfer system for transferring liquid from a plurality of containers to a plurality of destinations comprises a plurality of inlet valves. Each inlet valve is operable between an open position allowing liquid from a container to be drawn into the system and a closed position blocking liquid from a container from being drawn into the system. Liquid drawn from each of the liquid containers is delivered to a buffer chamber designed to degas the liquid in the buffer chamber. The buffer chamber leads to a vented feeder chamber that is also adapted to retain a volume of liquid. A chamber connection valve is provided between the buffer chamber and the feeder chamber to allow or block the flow of liquid between the buffer chamber and the feeder chamber. The feeder chamber is connected to a plurality of distribution valves operable to deliver liquid to a plurality of destinations.

Abstract: A disposable, contamination-indicating pipette for metering liquids containing a specified agent. The pipette has a main body portion having a volume V and a diameter D, an open-ended upper connection portion, and an open-ended lower tip portion. An indicator in the connection portion provides an observable indication that liquid has entered the connection portion.

Abstract: A trace sampling detection system includes a gathering device configured to gather particles through a handle-bar, a gate and an air-stream gatherer. The handle-bar includes collection holes positioned to be adjacent to a user's hand when the user grips the handle-bar, and is configured to dislodge and capture particles from the user's hand when the user grips and moves the handle-bar. The gate includes a series of collection holes, is positioned to be adjacent to the user's clothing when the user traverses the gate, and is configured to dislodge and capture particles from the user's clothing in response to pressure applied from the user. The air-stream gatherer includes an outward vent and an in-drawing vent, and is positioned to enable objects, such as the user's feet, to be placed between the outward and in-drawing vents. The air stream is configured to dislodge and capture particles from objects, such as the user's feet, that block the air-stream between the vents.

Abstract: A microfluidic device which comprises two or more microchannel structures (set 1), each of which comprises a structural unit which comprises (i) one or more inlet microconduits, and (ii) an outlet microconduit downstream said one or more inlet microconduits, and (iii) a flow path for a liquid passing through either of said inlet microconduits and said outlet microconduit. The device is characterized in that each outlet microconduit in said two or more microchannel structures is a restriction microconduit. There may also be a microcavity between the inlet microconduit(s) and the restriction microconduit in each microchannel structure. Typically common flow control is used for driving a liquid flow within the device. The innovative design is useful for creating flow with low inter-channel variation with respect to the microchannel structures of the device.

Abstract: An apparatus and a method are disclosed for providing point of care testing for osmolarity of a bodily fluid. An apparatus is disclosed as having a fluid pathway passing through it for receiving and testing a sample fluid. The invention permits osmolarity testing of a sample fluid wherein the sample fluid has a volume of less than approximately 30 nL, and implements a method and device to measure fluid osmolarity in a clinical setting quickly and accurately, while also reducing evaporation of the fluid.

Abstract: A sample preparation system for preparing a biological sample for testing is provided. The preparation system may include a sample preparation chamber including a biological sample, a waste collection chamber for storing waste liquid, a sample substrate, and a fluid management module. The fluid management module may be configured to selectively connect between two of the sample preparation chamber, the waste collection chamber, and the sample substrate in fluid communication. Methods of filling a sample substrate with a biological sample are also provided.

Abstract: A sensor dispensing instrument adapted to handle a sensor pack containing a plurality of sensors and to perform a test using one of the sensors, wherein the sensor dispensing instrument includes an electronics assembly for performing the test and displaying test results. The electronics assembly includes a printed circuit board having electrical components, at least one button, and a liquid crystal display mounted thereon. The electronics assembly is formed and tested prior to assembling the electronics assembly into the outer housing of the sensor dispensing instrument.

Abstract: [Problems] To suppress an increase in the discharge amount of harmful substances and operating cost in a cement kiln or the like. [Means for Solving Problems] This combustion exhaust gas G processing device comprises a dust collector 6 collecting dust in combustion exhaust gas G, a wet dust collector 7 collecting water soluble components and dust in the combustion exhaust gas G passed through the dust collector 6, and a catalyst tower 12 decomposing and removing NOx and/or dioxins in the combustion exhaust gas G passed through the wet dust collector 7.

Abstract: In a first aspect, a first abatement apparatus is provided. The first abatement apparatus includes (1) an oxidation unit adapted to receive an effluent stream from a semiconductor device manufacturing chamber; (2) a first water scrubber unit adapted to receive the effluent stream from the oxidation unit; and (3) a catalysis unit adapted to receive the effluent stream from the first water scrubber unit. Numerous other aspects are provided.

Abstract: The present invention provides an air filtration cartridge 1 suitable for use in the treatment of air in a forced airflow air supply system. The cartridge 1 comprises an inner casing 2 having an upstream stage 3 defining a chamber 4 having an inlet 5 for receiving a forced airflow 6. The chamber 4 has an outlet 7 which leads into a downstream stage 8 comprising a filter holder and mounting a high airflow electrostatic filter. Inside the chamber 4 is a low power coronal discharge ozone generator device 10.

Abstract: A transalkylation process for reacting carbon number nine aromatics with toluene to form carbon number eight aromatics such as para-xylene is herein disclosed. The process is based on the discovery that deactivating contaminants present in typical hydrocarbon feeds, such as chlorides, can be removed with an alumina guard bed prior to contacting with a transalkylation catalyst. Effective transalkylation catalysts have a solid-acid component such as mordenite, and a metal component such as rhenium. The invention is embodied in a process, a catalyst system, and an apparatus. The invention provides for longer catalyst cycle life when processing aromatics under commercial transalkylation conditions.

Abstract: A reformer system has a reformer for converting a hydrocarbon-containing fuel to a hydrogen-gas-rich reformate gas, and an HC adsorber, which is connected to an output side of the reformer and adsorbs, as a function of temperature, hydrocarbons contained in the reformate gas, or for desorbing previously adsorbed hydrocarbons to the reformate gas. The reformer system transmits the reformate gas after passing through the HC adsorber to a consuming device.

Abstract: A water treatment composition includes an oxidizing component and an absorbing component, wherein one or both of the oxidizing component and absorbing component comprise nanostructured materials. The water treatment compositions are useful in at least partially removing contaminants such as metallic or cationic arsenic, lead, chromium, and/or mercury from water.

Abstract: The present invention relates to a method for the production of trichlorosilane by reaction of silicon with HCl gas at a temperature between 250° and 1100° C., and an absolute pressure of 0.5-30 atm in a fluidized bed reactor, in a stirred bed reactor or a solid bed reactor, where the silicon supplied to the reactor contains between 30 and 10.000 ppm chromium. The invention further relates to silicon for use in the production of trichlorosilane by reaction of silicon with HCl gas, containing between 30 and 10.000 ppm 10 chromium, the remaining except for normal impurities being silicon.

Abstract: A SiC-based composite material capable of use as an inner coating for an aluminium smelting furnace or as an inner coating for a fused salt electrolytic cell, wherein said composite material has been prepared from a precursor mixture comprising at least one ?-SiC precursor and at least one carbonated resin, and wherein said composite material contains inclusions, and wherein at least one part thereof comprises ?-SiC, in a ?-SiC matrix.

Abstract: Disclosed is an aqueous solution of a chromium salt, in which the oxalic acid content is 8% by weight or less relative to chromium. In the aqueous solution of the chromium salt, the total organic carbon content is 4% by weight or less relative to chromium. The chromium salt is preferably a chromium chloride, a chromium phosphate, or a chromium nitrate. The chromium chloride preferably contains a basic chromium chloride represented by the composition formula Cr(OH)xCly (wherein 0<x?2, 1?y<3, and x+y=3). The chromium phosphate is preferably one represented by the composition formula Cr(H3?3/nPO4)n (wherein n is a number satisfying 2?n?3). The chromium nitrate is preferably a basic chromium nitrate represented by the composition formula Cr(OH)x(NO3)y (wherein 0<x?2, 1?y<3, and x+y=3).

Abstract: The present invention provides a method and apparatus for manufacturing halogen gas using a plasma chemical reaction, with the features of having simplicity, practicality, and maintaining safety in handling source materials and of being able to manufacture halogen gas in the same facility where halogen gas is used, and also provides a halogen gas circulatory and recovery system capable of circulating and using halogen gas efficiently. After the gas expressed in the chemical formula AiXj (A represents metallic element or semiconductor element, X represents halogen element, and i and j represent integers) is introduced into a reaction container in vacuum, plasmas are generated in the reaction container to produce a plasma chemical reaction. Fine particles produced by the plasma chemical reaction and containing an element other than halogen element as the major constituent are removed from the reaction container so as to generate halogen gas in the reaction container.

Abstract: Polymer-encapsulated ion-exchange resins are disclosed. The resins are useful in adsorption, catalysis, and other applications. Catalysts comprising a polymer-encapsulated combination of an ion-exchange resin and a transition metal are also disclosed. The catalysts are useful in hydrogenation, oxidation, hydroformylation, polymerization, and other valuable processes. Certain of the polymer-encapsulated catalysts enhance the productivity in the process for producing hydrogen peroxide from hydrogen and oxygen.

Abstract: The fine barium titanate particles of the present invention have an average primary particle diameter of from 10 nm to less than 20 nm, a sphericity of 1.00 to 1.18, and a ratio of an average secondary particle diameter to the average primary particle diameter of 0.7 to 6.0. The fine barium titanate particles of the present invention can exhibit a small behavior particle diameter and can be readily monodispersed notwithstanding very fine particles, and as a result, can be suitably used as various dielectric materials because the particles are free from aggregation therebetween and have an excellent dispersibility.

Abstract: The present invention concerns methods and compositions for making and using bioactive assemblies of defined compositions, which may have multiple functionalities and/or binding specificities. In particular embodiments, the bioactive assembly is formed using dock-and-lock (DNL) methodology, which takes advantage of the specific binding interaction between dimerization and docking domains (DDD) and anchoring domains (AD) to form the assembly. In various embodiments, one or more effectors may be attached to a DDD or AD sequence. Complementary AD or DDD sequences may be attached to an adaptor module that forms the core of the bioactive assembly, allowing formation of the assembly through the specific DDD/AD binding interactions. Such assemblies may be attached to a wide variety of effector moieties for treatment, detection and/or diagnosis of a disease, pathogen infection or other medical or veterinary condition.

Abstract: The present invention relates to methods and compositions designed for the treatment, management, or prevention of cancer, particularly, metastatic cancer. The methods of the invention comprise the administration of an effective amount of one or more antibodies that bind to and agonize EphA2, thereby increasing EphA2 phosphorylation and decreasing EphA2 levels in cells which EphA2 has been agonized. The invention also encompasses antibodies that preferentially bind an EphA2 epitope exposed on cancer cells but not non-cancer cells. The invention also provides pharmaceutical compositions comprising one or more EphA2 antibodies of the invention either alone or in combination with one or more other agents useful for cancer therapy.

Abstract: The invention provides radiopharmaceuticals for diagnostic and therapeutic applications, conjugates of antioxidants with metal chelating ligands, intermediate compounds, methods of making such radiopharmaceuticals, ligands, and intermediate compounds, and kits for preparing the radiopharmaceutical complexes.

Abstract: A preparation for the diagnosis of pancreatic exocrine function by determining the amount in which a substance administered to a subject or a degradation product or metabolite thereof migrates into the blood and/or is excreted out of the body, wherein the substance is carried by a carrier and released from the carrier when exposed to the action of a pancreatic exocrine function-related factor.

Abstract: The present invention relates, in general, to a method of assaying an immune response induced by an immunogen, and, more particularly, to a method of assaying a immunogen for its ability to induce a desired immune response, wherein the assay is effected in an autoimmune animal.

Abstract: A method is provided for selecting a pillow and mattress based upon an empirical measurement of an individual's pillow selection criteria, mattress selection criteria and sleep characteristics. A system incorporating the principles of the method are also disclosed.

Abstract: Various pathophysiological states are determined by evaluating the rate of 17O-containing water production oxygen using proton MRI. The method can be used to identify viable but threatened myocardium, injured by viable muscle, penumbra tissue in a stroke patient, and the like.

Abstract: This invention provides nanocrystals or polymer doped nanocrystals of hydrophobic organic fluorescent dyes as stable dispersions in an aqueous system. The dispersions can be prepared without stabilizers such as surfactants and the like. The aqueous dispersions of the nanocrystals or the polymer doped nanocrystals can be used for bioimaging.

Abstract: GAT2 is consistently expressed at high levels in brain microvessel endothelial cells. Disclosed herein are assays for determining whether a test material/molecule is a substrate for, and/or is actively transported by, the GAT2 transporter, and therefore a candidate substrate for crossing the blood brain barrier. The assays are useful in screening for therapeutic, cytotoxic or imaging compounds used in the treatment or diagnosis of neurological diseases.

Abstract: Fluorenecarboxylic acid esters of general formula 1 wherein X? and the groups A, R, R1, R2, R3, R3?, R4, and R4? have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof a medicaments.

Abstract: It has been discovered that by combining a chelator, such as ethylenediaminetetraacetic acid, with an acidifier, such as citric acid, the insulin is absorbed much more rapidly than in the absence of the chelator and acidifier, with a commercially available rapid, intermediate or long lasting insulin such as glargine, one can increase and/or prolong the bioavailability of the insulin mixture. The formulations are suitable for administration by injection or to a mucosal surface such as the pulmonary or oral regions, although subcutaneous injection is preferred.

Abstract: The present invention relates to a medicinal aerosol formulation product with improved chemical stability. The product is a pressurized metered dose inhaler including an aerosol canister equipped with a metering valve provided with sealing rings and/or gaskets made of a vulcanisate of an elastomeric composition of a butyl rubber, a cross-linking agent for the butyl rubber, and an accelerator for the cross-linking agent. The accelerator includes a polysulphide compound derived from a substituted dithiocarbonic acid or derivative thereof. The pressurized metered dose inhaler contains in the aerosol canister a medicinal aerosol formulation containing a long acting ?2 agonist, a hydrofluorocarbon propellant, a co-solvent, and a mineral acid as a stabilizer for the active ingredient.

Abstract: Methods for suppressing, killing, and inhibiting pathogenic cells, such as microorganisms associated with a respiratory infection within the respiratory tract of an animal are described. Methods include the step of exposing the pathogenic cells to an effective amount of nitric oxide, such as through inhalation of nitric oxide gas, in combination with traditional respiratory infection agents, such as antibiotics.

Abstract: The invention relates to a nasally applied, film-shaped, bioadhesive pharmaceutical form of administration containing at least one agent-containing layer that is based on crosslinked hydrophilic polymers comprising up to 60 percent by weight of Lidocaine, the percentage being in relation to the total quantity of crosslinked hydrophilic polymers. Also disclosed is the use thereof for controlling primary headaches, preferably migraine.

Abstract: The instant invention provides for a composition and method for using Kunitz-type serine protease inhibitors, e.g., aprotinin or bikunin, for stimulating the rate of mucociliary clearance of mucus and sputum in lung airways of subjects afflicted with mucociliary dysfunctions such as cystic fibrosis.

Abstract: A pharmaceutical composition comprising: (a) a compound of formula 1 wherein: n is 1 or 2; R1 is hydrogen, halogen, C1-4-alkyl, or O—C1-4-alkyl; R2 is hydrogen, halogen, C1-4-alkyl, or O—C1-4-alkyl; and R3 is hydrogen, C1-4-alkyl, OH, halogen, O—C1-4-alkyl, O—C1-4-alkylene-COOH, or O—C1-4-alkylene-COO—C1-4-alkyl, or an enantiomer, mixture of enantiomers, or racemate thereof, or an acid addition salt with pharmacologically acceptable acids thereof, or a solvate or hydrate thereof; and (b) another active substance 2, wherein the molar ratio of the compound of formula 1 to the active substance 2 is 1:10 to 12:1.

Abstract: Compositions and methods use the gel-forming properties of microporous particles to create useful formulations combining two free-flowing materials to produce a hydrogel mass. The free-flowing materials preferably provide dry microporous particles (preferably as an aerosol) that may contain additional agents, and a second composition of a fluid material which is an aqueous solution of one or more high molecular weight polymers capable of forming a hydrogel upon further concentration and/or reaction. The hydrogels can be preferably formed on a surface by spraying the two compositions as fluids together in the proper ratio onto the surface.

Abstract: The invention relates to an aerosol device with two compartments, which contains the following: (a) in a first compartment, a hair treatment composition comprising, in a cosmetically-acceptable aqueous medium, at least one compositionally-graded copolymer comprising at least two different monomers and having a mass polydispersity index (Ip) of less than or equal to 2.5; and (b) in a second compartment, a compressed gas which is selected from air, nitrogen, carbon dioxide and mixtures thereof and, optionally, at least one liquefied gas. The sprayed product can be used, for example, to shape and/or hold styled hair.

Abstract: Effective, non-invasive and non-destructive systems and methods provide an appearance of increased whiteness and/or brightness of the teeth, thereby enhancing the appearance of the teeth. One or more residual colors or dyes are applied to the surface of a tooth in order to complete the color spectrum of the tooth surface or more closely complete the color spectrum of the tooth surface, thereby enhancing the appearance of the tooth since a complete color spectrum appears as white. In one implementation, a residual color includes a shade of violet, wherein a red-violet reduces the yellow appearance of the tooth and a blue-violet enhances the brightness of the tooth. In one implementation, a bleaching step is performed to the surface of the tooth followed by the application of a residual color onto the surface of the tooth. In one implementation, a residual color includes a yellow shade applied to the surface of a tooth that otherwise appears gray to cause the tooth to appear whiter.

Abstract: A tooth whitening substance formed into a thin layer is provided. The tooth whitening substance includes a polyox resin and a tooth whitening active. The polyox resin adheres the thin layer to a plurality of teeth for a sufficient time to allow the tooth whitening active to act upon the plurality of teeth.

Abstract: A stable sunscreen composition comprising: (i) an organic UV-A sunscreen; (ii) an organic UV-B sunscreen; and (iii) cosmetically acceptable vehicle wherein said UV-A sunscreen and UV-B sunscreen are kept isolated from each other by encapsulating one of said sunscreens in solid lipid encapsulate, the solid lipid encapsulate comprising a lipid.

Abstract: A method for coloring hair with a hair care formulation that is mixed prior to use is provided. The method includes mixing together the components of the hair care formulation as the formulation is dispensed from a plastic applicator having at least one storage compartment for each component and a static or motionless mixer.

Abstract: A chrmonic nanoparticle mixture prepared by combining (i) a continuous water-soluble polymer phase and (ii) a discontinuous chromonic phase comprising a chromonic material; and non-covalently crosslinking the resulting chromonic nanoparticles with a polyvalent cation salt.

Abstract: A chromonic nanoparticle mixture prepared by combining (i) a continuous water-soluble polymer phase and (ii) a discontinuous chromonic phase comprising a chromonic material; and non-covalently crosslinking the resulting chromonic nanoparticles with a polyvalent cation salt.

Abstract: The invention relates to a cosmetic composition that can be used to remineralise human skin and to counteract the effects of ageing on the latter. According to the invention, said composition contains 0.5-3% water of volcanic origin containing 0.01-0.05 mg/l Fe, 100-300 mg/l K, 1,000-2,000 mg/l Na, 80-200 mg/l Mg, 50-150 mg/l Ca, 50-150 mg/l Si, 0.01-0.1 mg/l P, 0.001-0.005 mg/l Se, 0.01-0.03 mg/l Zn. In addition, the composition optionally contains 0.2-0.8% of an extract from samphire Crithmum maritimum, 0.3-0.9% of the peptide palmitoyl-gly-his-lys and 0.8-1.25% hydrolysed soy protein.

Abstract: Disclosed is a method of treatment of psoriasis which comprises administering to a patient in need thereof by the oral route a pharmaceutical composition comprising rosiglitazone, or a pharmaceutically acceptable salt or solvate thereof, together with a pharmaceutically acceptable carrier, wherein the method comprises administering 2 to 8 mg rosiglitazone per day.

Abstract: Compositions comprising an asymmetric disiloxane surfactant composition comprising a silicone composition comprising a silicone having the formula: MM? where M or M? comprises an alkylpolyalkyleneoxide bearing substituent selected from the group consisting of: R13(C2H4O)a(C3H6O)b(C4H8O)cR14 and R12SiR5R6(R13(C2H4O)a(C3H6O)b(C4H8O)cR14) that exhibit resistance to hydrolysis over a wide pH range.

Abstract: A composition for the treatment of hair. The composition consists essentially of mayonnaise being present in the composition in a concentration of between about 55 and 64 percent by weight. Olive oil is present in the composition in a concentration of between about 12 and 15 percent by weight, carrot oil is present in the composition in a concentration of between about 12 and 15 percent by weight, and collagen is present in the composition in a concentration of between about 12 and 15 percent by weight.

Abstract: A hair cleansing composition comprises the following ingredients (A) to (C): (A) a dicarboxylic acid or hydroxydicarboxylic acid, or a salt thereof, (B) an organic solvent, and (C) an anionic surfactant having a sulfate group; and has a pH of from 1 to 4 when diluted 20-fold by weight with water and a buffer capacity not lower than 0.005 gram equivalent/L but lower than 0.2 gram equivalent/L. The hair cleansing composition has good foamability and high-lubricity foam quality upon washing, and are excellent in the luster, softness and manageability of hair after drying and also superb in stability.

Abstract: A composition comprising a mixing product of: (i) a first acid having a pKa of less than 3, in an amount by weight of 1-10%, (ii) a second acid having a pKa of greater than 3, in an amount by weight of 1-10%, (iii) a nonionic surfactant in an amount by weight of 1-7%; and (vi) water; wherein the composition has a pH of less than 2.5. The composition can be used for the removal of grease, lime scale, soap scum and rust on hard surfaces.